Budget Amount *help |
¥18,720,000 (Direct Cost: ¥14,400,000、Indirect Cost: ¥4,320,000)
Fiscal Year 2010: ¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2009: ¥5,850,000 (Direct Cost: ¥4,500,000、Indirect Cost: ¥1,350,000)
Fiscal Year 2008: ¥7,930,000 (Direct Cost: ¥6,100,000、Indirect Cost: ¥1,830,000)
|
Research Abstract |
We performed the comprehensive analysis of microRNA expression profile to identify novel microRNAs which regulate invasiveness of pancreatic cancer. The cluster analysis identified miR-126 as a significantly down-regulated microRNA in invasive pancreatic cancer, which attenuates migration and invasion of pancreatic cancer cells. Furthermore, ADAM9 was newly identified as a target gene of miR-126, of which knockdown resulted in the decreased migration and invasion of pancreatic cancer cells. The miR-126/ADAM9 pathway could be a novel therapeutic target of invasive pancreatic cancer.
|